Русский

Pharmaceutical Industry Information Portal

News Feed

Drug manufacturers

Vladimir Shipkov: Foreign pharmaceutical companies continue to supply medicines to Russia

Techno -
Foreign pharmaceutical companies continue to work in Russia and supply medicines to the Russian market, Executive Director of the...

Binnopharm Group’s revenue for 1H 2022 goes up 16.3% to over RUB 12.6 bn

Techno -
Binnopharm Group, a pharmaceutical company, announces its unaudited consolidated IFRS financial results for the first half ended 30 June...

Moderna to build a new vaccine plant in the UK

Ekaterina -
U.S. biotech firm Moderna  will build a new research and manufacturing centre in Britain to develop vaccines against new...

Regulatory News

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Techno -
Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

FDA approves Sanofi’s Dupixent for widespread use in the United States

Ekaterina -
Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the...

U.S.FDA lifts ban on COVAXIN Covid-19 vaccine candidate study

Ekaterina -
Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, May 23th...

World Pharma News

Amgen sells its Turkish manufacturing arm for $135M

Ekaterina -
Amgen, which has been beefing up its U.S. manufacturing operations, sold its stake in Turkey’s oldest pharmaceutical company Gensenta...

Pfizer and BioNTech announce new $3.2 billion agreement to supply the COVID-19 vaccine to the US

Ekaterina -
Pfizer Inc. and BioNTech SE announced today a new vaccine supply agreement with the U.S. government, according to which...

Sanofi to cut out-of-pocket insulin costs to $35 for U.S. patients

Ekaterina -
French drugmaker Sanofi  said on Wednesday uninsured diabetes patients in the United States will pay no more than $35...

Don’t miss your daily PharmProm news.
SUBSCRIBE free here!

SUBSCRIBE

Expert Articles

GMP-inspections of veterinary manufacturers in the first half of 2022

Techno -
The review provides information related to the inspection of manufacturers of medicinal products for veterinary use for compliance with...

Combination of biomarkers discovered that can to identify subcortical small-vessel disease

Ekaterina -
In recent years, subcortical small-vessel disease has become an increasingly common cognitive diagnosis. Researchers at University of Gothenburg have...

New technologies are an integral part of diabetes management

Ekaterina -
A large population of people living with type 1 diabetes are set to be offered new technology to help...

Research and Development

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Techno -
Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Ekaterina -
Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta...

OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures

Ekaterina -
OSE Immunotherapeutics SA today announces that the Company is one of the first biotech startup companies selected by Microsoft...

Market analytics

Hikma Pharmaceuticals down 30%, stock to buy on fall

Ekaterina -
Hikma Pharmaceuticals is one of the biggest UK biotech stocks, only trailing giants like AstraZeneca and GlaxoSmithKline. Hikma was...

Pfizer, BioNTech shares rise after FDA approves Covid boosters for children

Ekaterina -
Pfizer Inc. and BioNTech SE May 17th announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization...

Sales of AstraZeneca’s COVID vaccine exceed forecasts Q1 revenue $11.39 billion

Ekaterina -
AstraZeneca PLC said Friday that it expects sales of total revenue from COVID-19 medicines is anticipated to decline by...

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories